SEC Form 4
Merck & Co., Inc. (MRK) insider trading
In the 12 months to Oct 24, 2026, 11 MRK insiders reported open-market sales of $72.0M across 21 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $72.0M
- 21 filings · 11 insiders
- Open-market purchases
- $0
- 0 filings
Who traded MRK, and when
- Sale
MRK daily close from Oct 24, 2025 to Oct 23, 2026, between $82.49 and $156.45, last $145.27. 21 sale and 0 purchase filings by 11 insiders, marked at their filing dates. Jennifer Zachary, EVP, General Counsel: sold $25.2M across 2 filings, first filed Feb 9, 2026, last Aug 13, 2026. Richard R. DeLuca, EVP&Pres, Merck Animal Heallth: sold $11.3M across 3 filings, first filed Feb 6, 2026, last Aug 12, 2026. Chirfi Guindo, Chief Marketing Officer → EVP, Access, Policy & Comms: sold $8.2M across 5 filings, first filed Feb 6, 2026, last Aug 13, 2026. David Michael Williams, EVP,Chief Info&Digital Officer: sold $8.1M across 3 filings, first filed Nov 4, 2025, last Aug 7, 2026. Robert M. Davis, Chairman, CEO & President: sold $5.6M across 1 filing, first filed Feb 6, 2026, last Feb 6, 2026. Caroline Litchfield, EVP & CFO: sold $5.0M across 1 filing, first filed Feb 6, 2026, last Feb 6, 2026. 5 others: sold $8.6M across 6 filings, first filed Nov 12, 2025, last Aug 7, 2026.
Largest mark · tap a row for others
Jennifer Zachary · EVP, General Counsel
Sale $14,485,690
121,573 shares at $119.15 avg
Filed Feb 9, 2026
Close on filing date $117.65
Jennifer Zachary · EVP, General Counsel
EVP, General Counsel
$25.2M soldRichard R. DeLuca · EVP&Pres, Merck Animal Heallth
EVP&Pres, Merck Animal Heallth
$11.3M soldChirfi Guindo · Chief Marketing Officer → EVP, Access, Policy & Comms
Chief Marketing Officer → EVP, Access, Policy & Comms
$8.2M soldDavid Michael Williams · EVP,Chief Info&Digital Officer
EVP,Chief Info&Digital Officer
$8.1M soldRobert M. Davis · Chairman, CEO & President
Chairman, CEO & President
$5.6M soldCaroline Litchfield · EVP & CFO
EVP & CFO
$5.0M sold5 others
Combined, one mark per week
$8.6M soldHas Merck & Co., Inc.'s CEO sold stock?
Yes. Robert M. Davis (CEO) sold 47,434 shares ($5.6M) in Feb 2026.
Open-market trades
21 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Jennifer Zachary | EVP, General Counsel | $25.2M | — | 2 | — | |
| Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | $11.3M | — | 3 | — | |
| Chirfi Guindo | Chief Marketing Officer → EVP, Access, Policy & Comms | $8.2M | — | 5 | — | |
| David Michael Williams | EVP,Chief Info&Digital Officer | $8.1M | — | 3 | — | |
| Robert M. Davis | Chairman, CEO & President | $5.6M | — | 1 | — | |
| Caroline Litchfield | EVP & CFO | $5.0M | — | 1 | — | |
| Dean Y. Li | Executive VP & President, MRL | $3.0M | — | 2 | — | |
| David R. Maraldo | EVP & Pres. MMD | $2.4M | — | 1 | — | |
| Johannes Jacobus Oosthuizen | President, U.S. Market | $1.8M | — | 1 | — | |
| Dalton E. Smart III | SVP Fin. - Global Controller | $765.9K | — | 1 | — | |
| Cristal N. Downing | Chief Comm. & Public Afrs Ofcr | $616.4K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Jennifer Zachary EVP, General Counsel | Sale | 80,315 | $133.46 | $10.7M | 45,509 | |
traded | Chirfi Guindo EVP, Access, Policy & Comms | Sale | 10,000 | $135.00 | $1.4M | 36,613 | |
traded | Richard R. DeLuca EVP&Pres, Merck Animal Heallth | Sale | 45,320 | $131.12 | $5.9M | 110,767 | |
traded | Richard R. DeLuca EVP&Pres, Merck Animal Heallth | Sale | 6,050 | $130.38 | $788.8K | 155,487 | |
traded | Chirfi Guindo EVP, Access, Policy & Comms | Sale | 15,000 | $131.00 | $2.0M | 46,613 | |
traded | David Michael Williams EVP,Chief Info&Digital Officer | Sale | 52,847 | $128.77 | $6.8M | 31,716 | |
traded | David R. Maraldo EVP & Pres. MMD | Sale | 18,706 | $128.72 | $2.4M | 18,212 | |
traded | Chirfi Guindo Chief Marketing Officer | Sale | 10,000 | $121.46 | $1.2M | 60,615 | |
traded | Dean Y. Li Executive VP & President, MRL | Sale | 10,235 | $117.52 | $1.2M | 92,035 | |
traded | Jennifer Zachary EVP, General Counsel | Sale | 121,573 | $119.15 | $14.5M | 68,916 | |
traded | Chirfi Guindo Chief Marketing Officer | Sale | 10,000 | $118.41 | $1.2M | 70,615 | |
traded | Robert M. Davis Chairman, CEO & President | Sale | 47,434 | $118.04 | $5.6M | 443,602 | |
traded | Richard R. DeLuca EVP&Pres, Merck Animal Heallth | Sale | 37,685 | $120.92 | $4.6M | 160,174 | |
traded | Chirfi Guindo Chief Marketing Officer | Sale | 20,000 | $121.88 | $2.4M | 80,615 | |
traded | Dean Y. Li Executive VP & President, MRL | Sale | 15,087 | $118.77 | $1.8M | 102,270 | |
traded | Caroline Litchfield EVP & CFO | Sale | 41,997 | $119.61 | $5.0M | 90,192 | |
traded | Johannes Jacobus Oosthuizen President, U.S. Market | Sale | 15,000 | $121.87 | $1.8M | 21,197 | |
traded | Dalton E. Smart III SVP Fin. - Global Controller | Sale | 6,400 | $119.68 | $765.9K | 8,205 | |
traded | David Michael Williams EVP,Chief Info&Digital Officer | Sale | 5,000 | $121.91 | $609.5K | 30,838 | |
traded | Cristal N. Downing Chief Comm. & Public Afrs Ofcr | Sale | 7,085 | $87.00 | $616.4K | 0 | |
traded | David Michael Williams EVP,Chief Info&Digital Officer | Sale | 8,614 | $83.59 | $720.0K | 24,578 |
GET /stocks/filings/vX/form-4?tickers=MRK&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"MRK"
],
"issuer_cik": "0000310158",
"owner_cik": "0001722753",
"accession_number": "0000310158-26-000223",
"form_type": "4",
"filing_date": "2026-08-13",
"period_of_report": "2026-08-13",
"issuer_name": "Merck & Co., Inc.",
"issuer_trading_symbol": "MRK",
"owner_name": "Guindo Chirfi",
"is_officer": true,
"officer_title": "EVP, Access, Policy & Comms",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-13",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 10000,
"transaction_price_per_share": 135,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 36613.127,
"transaction_value": 1350000,
"direct_or_indirect": "D"
},
{
"tickers": [
"MRK"
],
"issuer_cik": "0000310158",
"owner_cik": "0001737231",
"accession_number": "0000310158-26-000221",
"form_type": "4",
"filing_date": "2026-08-13",
"period_of_report": "2026-08-12",
"issuer_name": "Merck & Co., Inc.",
"issuer_trading_symbol": "MRK",
"owner_name": "Zachary Jennifer",
"is_officer": true,
"officer_title": "EVP, General Counsel",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-12",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 80315,
"transaction_price_per_share": 133.4557,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 45509.254,
"transaction_value": 10718494.545500001,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.0300 to $133.5000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 56 records
- Option exercises30 records
- Tax withholding15 records
- Grants and awards11 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for MRK every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Role
- The title on each filing. Someone whose title changed shows more than one.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.